Talaromyces marneffei infection with IFNGR1 gene mutation in a patient with negative Anti-Interferon-γ autoantibodies

TL;DR

A patient with Talaromyces marneffei infection was found to have a mutation in the IFNGR1 gene, suggesting a genetic risk factor for the disease.

Contribution

The study identifies a novel IFNGR1 gene mutation associated with TM infection in a patient without HIV or anti-interferon-γ autoantibodies.

Findings

A heterozygous mutation c.4C>T (p.L2F) was detected in the IFNGR1 gene.

The IFNGR1 gene mutation may be a potential risk factor for TM infection.

Anti-interferon-γ autoantibodies may worsen disease symptoms in TM infection.

Abstract

Talaromyces Marneffei (TM) is a rare opportunistic pathogen that mostly infects patients with low immunity compared to those with normal immunity. It may be related to immune deficiency or genetic factors.

To evaluate the gene mutation of a patient infected with TM in an endemic area with negative anti-interferon-γ autoantibodies, and negative human immunodeficiency virus (HIV) infection.

Extract deoxyribonucleic acid (DNA) samples from the patient's peripheral blood, detect the mutation gene by whole exome sequencing (WES), and carry out Sanger sequencing verification for the detected mutation gene.

The authors detected a mutation in the IFNGR1 gene (NM_001363526.1) and validated the detected gene mutation using Sanger sequencing. The results showed a heterozygous mutation c.4C>T (p.L2F) located in the IFNGR1 gene (NM_001363526.1).

The mechanism of the IFNGR1 gene has not been further investigated in this study.

The IFNGR1 gene mutation may be a potential risk factor for TM infection, and the presence of anti-interferon-γ autoantibodies can aggravate disease symptoms.

Figures